Heartware International Inc. (NASDAQ:HTWR) shares decreased -3.85% in last trading session and ended the day at $33.95. HTWR Gross Margin is 62.70% and its has a return on assets of -15.70%. Heartware International Inc. (NASDAQ:HTWR) quarterly performance is -1.54%.
HeartWare International, Inc. (NASDAQ: HTWR), announced a series of scientific presentations, highlighting the clinical and commercial use of the HVAD® System, at the International Society for Heart and Lung Transplantation (ISHLT) 36th Annual Meeting and Scientific Sessions to be held at the Marriott Wardman Park Hotel in Washington, D.C. on April 27-30, 2016.
Radio One Inc. (NASDAQ:ROIA) ended the last trading day at $1.95. Company weekly volatility is calculated as 9.16%. Radio One Inc. (NASDAQ:ROIA) showed a weekly performance of 10.17%.
Radio One, Inc. (NASDAQ:ROIA) will be holding a conference call for investors, analysts and other interested parties to discuss its results for the first fiscal quarter of 2016. The conference call is scheduled for Thursday, May 05, 2016 at 10:00 a.m. EDT.
On 25 April, Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares moved up 6.86% and was closed at $0.47. OREX EPS growth in last 5 year was 13.70%. Orexigen Therapeutics, Inc. (NASDAQ:OREX) year to date (YTD) performance is -72.66%.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced the appointment of Beth Eastland as Vice President of Sales and eight other additional new employees. In March 2016, Orexigen acquired full United States rights to Contrave® (naltrexone HCI and bupropion HCI), and the company is preparing to assume United States commercialization of the product later this year. Orexigen is launching an efficient U.S. commercial organization to execute a targeted, data-driven sales and marketing plan to drive the next phase of growth for Contrave.
RF Industries, Ltd. (NASDAQ:RFIL) shares moved up 5.18% in last trading session and ended the day at $2.64. RFIL Gross Margin is 33.00% and its has a return on assets of 1.80%. RF Industries, Ltd. (NASDAQ:RFIL) quarterly performance is -36.23%.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) caters to the Healthcare space. It has a net profit margin of -30.60% and weekly performance is -5.93%. On the last day of trading company shares ended up at $3.17.
On 11 April, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), announced that on March 14, 2016, Aegerion granted options to purchase 75,000 shares of common stock to one new employee; and on April 1, 2016, Aegerion granted options to purchase an aggregate of 57,775 shares of common stock to eight new employees under the inducement stock option program.
Leave a Reply